Why Neurotech Will Be the Gold Rush of the 21st Century

Why Neurotech Will Be the Gold Rush of the 21st Century

Source: 
Medical Devices and Diagnostics Industry
News Tags: 
snippet: 

Neurotech is moving quickly. In 2015, the U.S. neurostimulation devices market was valued at $2 billion, and Grand View Research estimates it to exceed $12 billion by 2023. While the primary aim is to treat and banish degenerative neurological diseases, neurotech has the power to unlock and interpret the brain’s complex workings and attract a gold rush of interest in the process.